SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-063164
Filing Date
2018-10-22
Accepted
2018-10-22 08:00:44
Documents
3
Period of Report
2018-10-22
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-37009_18k.htm 8-K 23386
2 EX-99.1 a18-37009_1ex99d1.htm EX-99.1 25036
3 GRAPHIC g370091moi001.jpg GRAPHIC 4013
  Complete submission text file 0001104659-18-063164.txt   55255
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 8-K | Act: 34 | File No.: 001-37569 | Film No.: 181131549
SIC: 2834 Pharmaceutical Preparations